These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16864815)

  • 1. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
    Qerama E; Fuglsang-Frederiksen A; Kasch H; Bach FW; Jensen TS
    Neurology; 2006 Jul; 67(2):241-5. PubMed ID: 16864815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
    Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
    Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
    Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
    J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injection in the cervical facet joint for shoulder pain with myofascial trigger points in the upper trapezius muscle.
    Tsai CT; Hsieh LF; Kuan TS; Kao MJ; Hong CZ
    Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL; Lee EH; Castaneda A; Klima R; Date E
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
    Graboski CL; Gray DS; Burnham RS
    Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased spontaneous electrical activity at a latent myofascial trigger point after nociceptive stimulation of another latent trigger point.
    Fernández-Carnero J; Ge HY; Kimura Y; Fernández-de-Las-Peñas C; Arendt-Nielsen L
    Clin J Pain; 2010 Feb; 26(2):138-43. PubMed ID: 20090441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
    Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
    Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A; Barnes M; Comiskey C
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographical mapping and mechanical pain sensitivity of myofascial trigger points in the infraspinatus muscle.
    Ge HY; Fernández-de-Las-Peñas C; Madeleine P; Arendt-Nielsen L
    Eur J Pain; 2008 Oct; 12(7):859-65. PubMed ID: 18203637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the effects of botulinum toxin injection on myofascial trigger points placebo effects or needling effects?
    Hsieh RL; Lee WC
    Arch Phys Med Rehabil; 2008 Apr; 89(4):792-3; author reply 793. PubMed ID: 18374016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.